Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 12
Submit an article Journal homepage
167
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bortezomib-associated tumor lysis syndrome in multiple myeloma

Michelle Furtado Department of Haematology, Derriford Hospital, Plymouth, Devon, England, UKCorrespondencemichelle@[email protected] [email protected]
&
Simon Rule Department of Haematology, Derriford Hospital, Plymouth, Devon, England, UK
Pages 2380-2382 | Received 12 Sep 2008, Accepted 14 Sep 2008, Published online: 01 Jul 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Belal M. Firwana, Rim Hasan, Nour Hasan, Fares Alahdab, Iyad Alnahhas, Seba Hasan & Joseph Varon. (2012) Tumor Lysis Syndrome: A Systematic Review of Case Series and Case Reports. Postgraduate Medicine 124:2, pages 92-101.
Read now

Articles from other publishers (13)

Gabriela Lupușoru, Ioana Ailincăi, Georgiana Frățilă, Oana Ungureanu, Andreea Andronesi, Mircea Lupușoru, Mihaela Banu, Ileana Văcăroiu, Constantin Dina & Ioanel Sinescu. (2022) Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology. Biomedicines 10:5, pages 1012.
Crossref
Masahiro Kondo, Yuji Hotta, Karen Yamauchi, Akimasa Sanagawa, Hirokazu Komatsu, Shinsuke Iida & Kazunori Kimura. (2020) Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study. BMC Cancer 20:1.
Crossref
Akimasa Sanagawa, Yuji Hotta, Masahiro Kondo, Ryohei Nishikawa, Masahiro Tohkin & Kazunori Kimura. (2020) Tumor lysis syndrome associated with bortezomib: A post-hoc analysis after signal detection using the US Food and Drug Administration Adverse Event Reporting System. Anti-Cancer Drugs 31:2, pages 183-189.
Crossref
Abhijai Singh, Shweta Gupta, Barbara Yim & Romy Thekkekara. (2016) Tumor Lysis Syndrome in Multiple Myeloma: An Increasingly Recognized Risk?A Report of Seven Cases. Indian Journal of Hematology and Blood Transfusion 33:1, pages 41-44.
Crossref
Li Wang, Yuan Jian, Guangzhong Yang, Wen Gao, Yin Wu & Lihong Zuo. (2015) Management of Tumor Lysis Syndrome in Patients With Multiple Myeloma During Bortezomib Treatment. Clinical Journal of Oncology Nursing 19:1, pages E4-E7.
Crossref
F. Perry Wilson & Jeffrey S. Berns. (2014) Tumor Lysis Syndrome: New Challenges and Recent Advances. Advances in Chronic Kidney Disease 21:1, pages 18-26.
Crossref
Shinae Yu, Sung Woo Ryu, Kyoung-Ha Kim, Se-Hyoung Kim, Nam-Su Lee, Sung-Kyu Park & Jong-Ho Won. (2013) Bortezomib Induced Tumor Lysis Syndrome in Multiple Myeloma. Soonchunhyang Medical Science 19:1, pages 31-33.
Crossref
F. Perry Wilson & Jeffrey S. Berns. (2012) Onco-Nephrology. Clinical Journal of the American Society of Nephrology 7:10, pages 1730-1739.
Crossref
P. Bose & O. Qubaiah. (2011) A review of tumour lysis syndrome with targeted therapies and the role of rasburicase. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 299-326.
Crossref
Robert E. Lynch & Ellen G. Wood. 2011. Pediatric Critical Care. Pediatric Critical Care 944 962 .
Meletios A. Dimopoulos, Christine Chen, Efstathios Kastritis, Maria Gavriatopoulou & Steven P. Treon. (2010) Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma and Leukemia 10:2, pages 110-117.
Crossref
J J Shah & R Z Orlowski. (2009) Proteasome inhibitors in the treatment of multiple myeloma. Leukemia 23:11, pages 1964-1979.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.